Three very successful initial public offerings, a surge in genomics stocks, and the biggest biotech private placement to date suggest that biotechnology is once again back in favor with investors.

Newsletters, Alerts and Recommendations Get personalised news and exciting deals Bookmark the stories you want to read later REGISTER FOR FREE ...